Patrushev L I, Zykova E S, Kaiushin A L, Korosteleva M D, Miroshnikov A I
Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, Moscow, Russia.
Bioorg Khim. 1998 Mar;24(3):194-200.
A straightforward and effective PCR-based assay system is devised that allows one to reveal and identify homozygous and heterozygous point mutations. The system uses two sets of allele-specific primers. In one set, the 3'-nucleotide matches the allele under study so that the primer functions effectively only if the DNA contains the corresponding allele. To increase primer specificity, template-noncomplementary nucleotides are introduced near its 3'-end. The primers from another set invariably bear a 3'-terminal mismatch, and, in addition, the mutant nucleotides of the alleles under study form mismatches with the internal nucleotides of the primers. In such combination, the primer activity is suppressed if the DNA contains a homozygous mutation. The assay system devised was utilized to reveal the Leiden mutation in the gene for factor V of the human blood clotting system in patients with thrombophilia.
设计了一种简单有效的基于聚合酶链反应(PCR)的检测系统,该系统能够揭示和鉴定纯合子和杂合子点突变。该系统使用两组等位基因特异性引物。在一组引物中,3'-核苷酸与所研究的等位基因匹配,这样只有当DNA包含相应等位基因时,引物才能有效发挥作用。为了提高引物特异性,在其3'-末端附近引入与模板不互补的核苷酸。另一组引物的3'-末端总是存在错配,此外,所研究等位基因的突变核苷酸与引物的内部核苷酸形成错配。在这种组合中,如果DNA含有纯合突变,引物活性就会受到抑制。所设计的检测系统被用于揭示血栓形成倾向患者人类凝血系统因子V基因中的莱顿突变。